Resurgence of COVID-19 symptoms in patients treated with Pfizer Inc.’s Paxlovid appeared far more common than has been reported, and rebounding patients still risked spreading the disease, doctors said in a report on a series of cases in a top medical journal.
COVID rebound symptoms, positive tests after Paxlovid more common than reported, study says
Tweet <--- Like this post? You know what to do.


